"Welcome to Wagner Macula & Retina Center, specializing in diabetic retinopathy, macular degeneration, eye tumors, and the diagnosis and management of complex medical and surgical eye disease. We are the preferred referral for National Retina Centers of Excellence and the preeminent provider of adult and pediatric macula and retina treatments located in the Hampton Roads region of Virginia & North Carolina. Our state-of-the-art facilities offer the latest technology and treatments to save your eyesight."

During the past decade, Wagner Macula & Retina Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wagner Macula & Retina Center" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Genentech, Inc." with 6 trials sponsored, "Allergan" with 1 trials sponsored, "Kapil Kapoor" with 1 trials sponsored and "Notal Vision Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wagner Macula & Retina Center" #1 collaborator was "MEDARVA Foundation" with 1 trials as a collaborator and "ThromboGenics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wagner Macula & Retina Center" are "Diabetic Macular Edema" (5 trials), "Geographic Atrophy" (5 trials), "Neovascular Age-related Macular Degeneration" (3 trials), "Diabetic Retinopathy" (2 trials) and "Macular Degeneration" (2 trials). Many other conditions were trialed in "Wagner Macula & Retina Center" in a lesser frequency.

Most popular intervention types in "Wagner Macula & Retina Center" are "Drug" (20 trials), "Other" (5 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Ranibizumab" (3 trials), "Aflibercept" (2 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wagner Macula & Retina Center" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Wagner Macula & Retina Center". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Wagner Macula & Retina Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Wagner Macula & Retina Center, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".